Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shiratori

Showing results (201-210 of 215) with videos related to

Pageof 22
Sort By:
Gut|April 15, 2004
A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstructionH Isayama, Y Komatsu, T Tsujino, et al.
Cancer|March 30, 2000
Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAsS Maeda, H Yoshida, K Ogura, et al.
Journal of Hepatology|August 22, 2000
Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-betaY Shiratori, A S Perelson, L Weinberger, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 25, 2002
The enzymatic basis for the conversion of nonfucosylated to fucosylated alpha-fetoprotein by acyclic retinoid treatment in human hepatoma cells: activation of alpha1-6 fucosyltransferaseK Noda, E Miyoshi, T Kitada, et al.
Digestive Diseases and Sciences|April 5, 2000
Sustained viral response is rarely achieved in patients with high viral load of HCV RNA by excessive interferon therapyY Shiratori, N Kato, H Yoshida, et al.
Journal of Gastroenterology|January 5, 2002
Usefulness of MR imaging in the postsurgical monitoring of gallbladder cancer in a patient with bile duct cancer that developed 7 years after resection of mucinous adenocarcinoma of the gallbladderS Takai, Y Shiratori, M Kanematsu, et al.
Hepatology (Baltimore, Md.)|June 1, 1996
Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase geneF Kanai, Y Shiratori, Y Yoshida, et al.
Japanese Heart Journal|October 19, 2001
Enhancement of endothelial nitric oxide production by chenodeoxycholic acids in patients with hepatobiliary diseasesK Chisaki, T Nakajima, K Iwasawa, et al.
Liver|August 26, 2000
A prospective study of interferon therapy modified by pre-treatment viral load in cirrhotic patients. Tokyo-Chiba Hepatitis Research GroupY Shiratori, M Moriyama, F Imazeki, et al.
Hepatology (Baltimore, Md.)|April 27, 1999
Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNAY Shiratori, O Yokosuka, R Nakata, et al.
Pageof 22

Showing results (201-210 of 215) with videos related to

Sort By:
Pageof 22
Gut|April 15, 2004
A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstructionH Isayama, Y Komatsu, T Tsujino, et al.
Cancer|March 30, 2000
Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAsS Maeda, H Yoshida, K Ogura, et al.
Journal of Hepatology|August 22, 2000
Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-betaY Shiratori, A S Perelson, L Weinberger, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 25, 2002
The enzymatic basis for the conversion of nonfucosylated to fucosylated alpha-fetoprotein by acyclic retinoid treatment in human hepatoma cells: activation of alpha1-6 fucosyltransferaseK Noda, E Miyoshi, T Kitada, et al.
Digestive Diseases and Sciences|April 5, 2000
Sustained viral response is rarely achieved in patients with high viral load of HCV RNA by excessive interferon therapyY Shiratori, N Kato, H Yoshida, et al.
Journal of Gastroenterology|January 5, 2002
Usefulness of MR imaging in the postsurgical monitoring of gallbladder cancer in a patient with bile duct cancer that developed 7 years after resection of mucinous adenocarcinoma of the gallbladderS Takai, Y Shiratori, M Kanematsu, et al.
Hepatology (Baltimore, Md.)|June 1, 1996
Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase geneF Kanai, Y Shiratori, Y Yoshida, et al.
Japanese Heart Journal|October 19, 2001
Enhancement of endothelial nitric oxide production by chenodeoxycholic acids in patients with hepatobiliary diseasesK Chisaki, T Nakajima, K Iwasawa, et al.
Liver|August 26, 2000
A prospective study of interferon therapy modified by pre-treatment viral load in cirrhotic patients. Tokyo-Chiba Hepatitis Research GroupY Shiratori, M Moriyama, F Imazeki, et al.
Hepatology (Baltimore, Md.)|April 27, 1999
Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNAY Shiratori, O Yokosuka, R Nakata, et al.
Pageof 22